2.36
0.05 (2.15%)
Market Trend
| Short Term | Medium Term | ||
| Industry | Drug Manufacturers - Specialty & Generic (US) | Mixed | Mixed |
| Drug Manufacturers - Specialty & Generic (Global) | Mixed | Mixed | |
| Stock | Cronos Group Inc. Common Share | Bullish | Mixed |
Stockmoo Score
|
Cronos Group, headquartered in Toronto, Canada, cultivates and sells medicinal and recreational cannabis through its medicinal brand, Peace Naturals, and its two recreational brands, Cove and Spinach. Although it primarily operates in Canada, Cronos exports medical cannabis primarily to Israel. In the US, the company has an option to acquire 5.9% of US multistate operator PharmaCann on a fully diluted basis upon easing of federal prohibition. |
|
| Sector | Healthcare |
| Industry | Drug Manufacturers - Specialty & Generic |
| Investment Style | Small Growth |
Ownership
| Name | Date | Shares Held |
|---|---|---|
| Intact Investment Management Inc. | 31 Mar 2024 | 607,390 |
No data within this time range.
No data within this time range.
| Date | Type | Details |
|---|---|---|
| 28 Aug 2024 | Announcement | Lord Jones® Live Resin Vapes and Ice Water Hash Pre-Rolls Now Available Across Canada |
| 08 Aug 2024 | Announcement | Cronos Group Reports 2024 Second Quarter Results |
| 25 Jul 2024 | Announcement | Cronos Group Inc. to Hold 2024 Second Quarter Earnings Conference Call on August 8, 2024 |
| 22 Jul 2024 | Announcement | Cronos Group Inc. Announces Results of Reconvened 2024 Annual Meeting of Shareholders |
| 05 Jul 2024 | Announcement | Cronos Group Inc. to Reconvene Virtual 2024 Annual Meeting of Shareholders |
| 27 Jun 2024 | Announcement | Cronos Brand Spinach® Celebrates Summer with New Launches |
| 21 Jun 2024 | Announcement | Cronos Group Inc. Announces Results of 2024 Annual Meeting of Shareholders |
| 20 Jun 2024 | Announcement | Cronos Group Announces Expansion of GrowCo to Fuel Global Growth |
The support, resistance and trendline levels presented has been generated by an artificial intelligence (AI) model and should be interpreted with caution.
Portfolio
| Realized Profit | - |
| Unrealized Profit | - |
| Dividend Received 2024 | - |
| Total Profit | - |
| Avg. Return | - |
| Quantity (Buy) | - |
| Avg. Price (Buy) | - |
| Quantity (Sold) | - |
| Avg. Price (Sold) | - |